Health-related quality of life and costs of receiving add-on therapy with insulin glargine or pioglitazone in patients with type 2 diabetes

被引：0
|
作者：
Meneghini, L.
Schwartz, S.
Strange, P.
Oster, G.
机构：
[1] Univ Miami, Miller Sch Med, Coral Gables, FL 33124 USA
[2] Diabet & Glandular Dis Res Associates, San Antonio, TX USA
[3] Sanofi Aventis US, US Med Affairs, Bridgewater, MA USA
[4] Policy Anal Inc, Brookline, MA USA
来源：
DIABETOLOGIA | 2006年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0894
引用
收藏
页码：543 / 543
页数：1
相关论文
共 50 条
  • [1] Health-related quality of life (HRQL) in patients with type 2 diabetes (T2DM), receiving add-on therapy with insulin glargine (GLAR) or pioglitazone (PIO)
    Oster, G.
    Meneghini, L. F.
    Schwartz, S.
    Zhang, Q.
    DIABETES, 2006, 55 : A477 - A477
  • [2] Pleiotropic effects of add-on therapy with pioglitazone, metformin or the combination of both in patients with type 2 diabetes on stable insulin glargine therapy
    Kleine, I. E.
    Fuchs, W.
    Pfuetzner, A.
    Forst, T.
    Hanefeld, M.
    DIABETOLOGIA, 2011, 54 : S374 - S374
  • [3] IMPROVED GLYCEMIC CONTROL WITH INSULIN GLARGINE VERSUS PIOGLITAZONE AS ADD-ON THERAPY TO SULFONYLUREA OR METFORMIN IN PATIENTS WITH UNCONTROLLED TYPE 2 DIABETES MELLITUS
    Meneghini, Luigi F.
    Traylor, Louise
    Schwartz, Sherwyn L.
    ENDOCRINE PRACTICE, 2010, 16 (04) : 588 - 599
  • [4] Investigation of treatment satisfaction and health-related quality of life after add-on to metformin-based therapy in patients with type 2 diabetes
    Chang, Yu-Wen
    Shen, Feng-Chin
    Chen, Chung-Yu
    FRONTIERS IN PUBLIC HEALTH, 2023, 11
  • [5] Renal function preservation with pioglitazone or with basal insulin as an add-on therapy for patients with type 2 diabetes mellitus
    Yu-Hung Chang
    Der-Wei Hwu
    Dao-Ming Chang
    Ling-Wang An
    Chang-Hsun Hsieh
    Yau-Jiunn Lee
    Acta Diabetologica, 2017, 54 : 561 - 568
  • [6] Differences in effects of insulin glargine or pioglitazone added to oral anti-diabetic therapy in patients with type 2 diabetes What to add-Insulin glargine or pioglitazone?
    Dorkhan, Mozhgan
    Frid, Anders
    Groop, Leif
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 82 (03) : 340 - 345
  • [7] Renal function preservation with pioglitazone or with basal insulin as an add-on therapy for patients with type 2 diabetes mellitus
    Chang, Yu-Hung
    Hwu, Der-Wei
    Chang, Dao-Ming
    An, Ling-Wang
    Hsieh, Chang-Hsun
    Lee, Yau-Jiunn
    ACTA DIABETOLOGICA, 2017, 54 (06) : 561 - 568
  • [8] Insulin glargine improves glycemic control and health-related quality of life in type 1 diabetes
    Manini, Rita
    Forlani, Gabriele
    Moscatiello, Simona
    Zannoni, Chiara
    Marzocchi, Rebecca
    Marchesini, Giulio
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2007, 17 (07) : 493 - 498
  • [9] Linagliptin as add-on therapy to insulin for patients with type 2 diabetes
    von Websky, Karoline
    Reichetzeder, Christoph
    Hocher, Berthold
    VASCULAR HEALTH AND RISK MANAGEMENT, 2013, 9 : 681 - 694
  • [10] Adding insulin glargine versus rosiglitazone - Health-related quality-of-life impact in type 2 diabetes
    Vinik, Aaron I.
    Zhang, Quanwu
    DIABETES CARE, 2007, 30 (04) : 795 - 800
12345